Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Moberg Pharma AB logo — Moberg Pharma AB (publ) is a Swedish pharmaceutical company...

Moberg Pharma AB

Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations

Founded 2006 Sweden Sweden 21 employees Post-IPO Equity Total: $243.70M Health Care

General Information

Company Name Moberg Pharma AB
Founded Year 2006
Location Sweden Sweden
Employees 21
Industries Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Moberg Pharma AB. To contact Moberg Pharma AB, visit mobergpharma.se.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Moberg Pharma AB compare?

A PDF of Moberg Pharma AB and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Moberg Pharma AB soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Moberg Pharma AB

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations. Established in 2006, the company's flagship asset, MOB-015, is an externally administered treatment for nail fungus. Clinical phase 3 studies involving over 800 patients have shown the potential for MOB-015 to become a leading product in the nail fungus market. Moberg Pharma has secured commercial partnerships in Europe and Canada, with plans to obtain market approval and initiate the launch of MOB-015 by 2023. The company, headquartered in Stockholm, is listed on Nasdaq Stockholm (OMX: MOB). In its latest funding round in March 2020, Moberg Pharma secured a post-IPO equity investment of kr216.00M, with the investment coming from Nice & Green SA. The company operates within the Health Care industry.

Business keywords: pharmaceutical company, Swedish, proprietary innovations, nail fungus treatment, clinical trials, market potential, commercial partners, stock exchange listing, Small Cap company, Nasdaq Stockholm, MOB-015, market approval, product launch, Europe, Canada

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity kr216.00M 1
Nice & Green SA
Nice & Green SA
23 Mar 2020
Series B kr27.70M -
28 Jun 2007

Moberg Pharma AB Alternatives & Competitors

Moberg Pharma AB vs
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF)
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF) Canada

Cipher Pharmaceuticals (TSX: CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a diversi...

Post-IPO Debt
65 employees
Health Care, Pharmaceutical

FAQ About Moberg Pharma AB

Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations
Moberg Pharma AB was founded in 2006.
Moberg Pharma AB is headquartered in Sweden.
Moberg Pharma AB operates in Health Care. Its work centres on pharmaceutical company, Swedish, proprietary innovations and nail fungus treatment.
Moberg Pharma AB has approximately 21 employees.
Moberg Pharma AB has completed 2 funding rounds, raising a total of $243.70M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Moberg Pharma AB include Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Moberg Pharma AB and Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Moberg Pharma AB, https://bouncewatch.com/company/moberg-pharma-ab, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout